DNA
Ginkgo Bioworks Holdings, Inc.
stockNYSE
At CloseNov 13, 2026 3:59:59 PM EST
9.61USD-6.061%(-0.62)1,859,962
Pre-marketNov 13, 2026 9:21:30 AM EST
10.30USD+0.684%(+0.07)
After-hoursNov 13, 2026 4:42:30 PM EST
9.5819USD-0.292%(-0.0281)
Loading…
Loading…
624.91M
Healthcare
Biotechnology
HQ
Boston, MA, USA
1,292
Previous Close
$10.23
Beta
3.23
52-Week High
$18.22 2026-10-06
52-Week Low
$5.37 2026-03-30
SMA 50
$10.24
SMA 200
$8.64
Avg. Vol 10D
2.68M
Avg. Vol 30D
3.23M
Avg. Vol 90D
2.01M
Relative Vol
0.50
64.83M
49.11M
75.76%
9,490,310
19.32%
3.85
56%/44%
54.89%
29.71%
0.4100%
250,000
4,934
4,944
18,216
Aug 20, 2024 · 1-for-40 (reverse)
100.7M
-251.0M
-173.5M
-242.52
-52.71
Nov 12, 2026
Nov 11, 2026
Nov 7, 2026
Ginkgo Bioworks: 3 Key Takeaways for Long-Term Investors · 
The Motley Fool+1 source
Nov 6, 2026
Ginkgo Bioworks (DNA) Q3 2026 Earnings Call Transcript · The Motley Fool
DNA Profile
the organism company ginkgo bioworks engineers new organisms to solve challenges across a range of industries from fuels to pharmaceutical production. our biological engineers make use of an in-house pipeline of synthetic biology technologies to design, build, and test new organisms.
DNA Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 11.29 | 2026-11-06 | -14.62% | 1.947 |
| 1M | 11.76 | 2026-10-13 | -18.03% | 3.830 |
| 3M | 7.24 | 2026-08-13 | +33.15% | 3.957 |
| 6M | 8.59 | 2026-05-13 | +12.22% | 3.005 |
| 1Y | 8.00 | 2025-11-13 | +20.50% | 3.230 |
| 2Y | 8.60 | 2024-11-13 | +12.09% | — |
| 5Y | 516.00 | 2021-11-12 | -98.13% | 2.545 |
DNA Stock Summary
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) stock price today is $9.64, and today's volume is 1,614,031. DNA is down 5.767% today. The 30 day average volume is 3.23M. DNA market cap is $624.91M with 64.83M shares outstanding.